Results for tag: "Austedo"

Austedo (tolcapone) is a drug used to treat movement disorders, such as tardive dyskinesia and Huntington's disease. It is a centrally acting, reversible, selective inhibitor of catechol-O-methyltransferase (COMT). It works by blocking the enzyme that breaks down dopamine, a neurotransmitter that helps regulate movement. This allows dopamine to remain in the brain longer, which can help reduce the symptoms of movement disorders. Austedo is part of a larger market of Central Nervous System (CNS) drugs, which are used to treat a variety of neurological conditions. These drugs can be used to treat conditions such as depression, anxiety, insomnia, and epilepsy. They can also be used to treat conditions such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. The Austedo market is comprised of a variety of companies, including Teva Pharmaceuticals, Lundbeck, and Sunovion Pharmaceuticals. Other companies in the market include Otsuka Pharmaceuticals, Merck, and Pfizer. Show Less Read more